These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30551777)

  • 1. Recent advances in antimicrobial and bacterial resistance.
    Chouchani C; Rolain JM; Ghrairi T
    Int J Antimicrob Agents; 2018 Dec; 52(6):869-870. PubMed ID: 30551777
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
    Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Badal RE; Xu Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):245-51. PubMed ID: 26482308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiresistant Enterobacteriaceae: new threat of an old problem.
    Pitout JD
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):657-69. PubMed ID: 18847404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New broad-spectrum β-lactamases emerging among Enterobacteriaceae from healthy cats and dogs: a public health concern?
    Smet A; Vaes R; Praud K; Doublet B; Daminet S; Cloeckaert A; Haesebrouck F
    Int J Antimicrob Agents; 2014 Jul; 44(1):81-2. PubMed ID: 24916079
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.
    Dupont H; Gaillot O; Goetgheluck AS; Plassart C; Emond JP; Lecuru M; Gaillard N; Derdouri S; Lemaire B; Girard de Courtilles M; Cattoir V; Mammeri H
    Antimicrob Agents Chemother; 2016 Jan; 60(1):215-21. PubMed ID: 26482307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new medical challenge: why NDM-1? Why Indian?
    Walsh TR; Toleman MA
    Expert Rev Anti Infect Ther; 2011 Feb; 9(2):137-41. PubMed ID: 21342058
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial resistance among Enterobacteriaceae in South America: history, current dissemination status and associated socioeconomic factors.
    Bonelli RR; Moreira BM; Picão RC
    Drug Resist Updat; 2014 Apr; 17(1-2):24-36. PubMed ID: 24618111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus pneumoniae Serotypes 9 and 14 Circulating in Brazil over a 23-Year Period Prior to Introduction of the 10-Valent Pneumococcal Conjugate Vaccine: Role of International Clones in the Evolution of Antimicrobial Resistance and Description of a Novel Genotype.
    Pinto TC; Kegele FC; Dias CA; Barros RR; Peralta JM; Merquior VL; Carvalho MD; Chochua S; Hawkins P; McGee L; Teixeira LM
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6664-6672. PubMed ID: 27572394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Genome Sequence of a blaOXA-48-Harboring Raoultella ornithinolytica Clinical Isolate from Lebanon.
    Al-Bayssari C; Olaitan AO; Leangapichart T; Okdah L; Dabboussi F; Hamze M; Rolain JM
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2548-50. PubMed ID: 26833149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
    Rodríguez-Baño J; Cisneros JM; Gudiol C; Martínez JA
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():49-55. PubMed ID: 25542052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of multiresistance in Enterobacteria].
    Martínez Martínez L
    Rev Esp Quimioter; 2006 Mar; 19(1):87-8. PubMed ID: 16688300
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug resistance and molecular epidemiology of aerobic bacteria isolated from puerperal infections in Bangladesh.
    Ahmed S; Kawaguchiya M; Ghosh S; Paul SK; Urushibara N; Mahmud C; Nahar K; Hossain MA; Kobayashi N
    Microb Drug Resist; 2015 Jun; 21(3):297-306. PubMed ID: 25555043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
    Oteo J; Miró E; Pérez-Vázquez M; Navarro F
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging carbapenem resistance in the context of a new metallo-beta-lactamase (NDM-1).
    Basu S; Singh AK; Nair GB
    Natl Med J India; 2010; 23(5):261-2. PubMed ID: 21250578
    [No Abstract]   [Full Text] [Related]  

  • 16. Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study.
    Robin F; Beyrouthy R; Bonacorsi S; Aissa N; Bret L; Brieu N; Cattoir V; Chapuis A; Chardon H; Degand N; Doucet-Populaire F; Dubois V; Fortineau N; Grillon A; Lanotte P; Leyssene D; Patry I; Podglajen I; Recule C; Ros A; Colomb-Cotinat M; Ponties V; Ploy MC; Bonnet R
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings of the ESCMID Conference on Extended-spectrum Beta-lactamases.
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():1-202. PubMed ID: 18376442
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
    Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
    López-Hernández I; Alonso N; Fernández-Martínez M; Zamorano L; Rivera A; Oliver A; Conejo MC; Martínez-Martínez L; Navarro F; Pascual A
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):499-504. PubMed ID: 27887765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: what is in the pipeline?
    Horcajada JP; Torre-Cisneros J; Peña C; Fariñas MC
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():56-60. PubMed ID: 25542053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.